Predict your next investment

InSphero company logo
HEALTHCARE | Drug Discovery
insphero.com

See what CB Insights has to offer

Founded Year

2009

Stage

Incubator/Accelerator | Alive

Total Raised

$37.1M

About InSphero

InSphero is biotech company focusing on industrial-grade, 3D-cell-based assay solutions and 3D organ-on-a-chip technology. Through partnerships, InSphero supports pharmaceutical and biotechnology researchers in successful decision-making by accurately rebuilding the human physiology in vitro. Its robust and precisely engineered suite of 3D InSight™ human tissue platforms are used by major pharmaceutical companies worldwide to increase efficiency in drug discovery and safety testing. The company specializes in liver toxicology, metabolic diseases (e.g., diabetes and NASH liver disease), and immuno oncology.

InSphero Headquarter Location

Wagistrasse 27

Schlieren, CH-8952,

Switzerland

+41 44 515049-0

Latest InSphero News

Insights on the 3D Cell Culture Global Market to 2026 - Featuring CN Bio Innovations, Corning and InSphero Among Others - ResearchAndMarkets.com

Jan 21, 2022

Key Market Trends The Microchips Segment under Product is Expected to see Significant Growth Rate Over the Forecast Period Microchips are also called organ-on-a-chip or microsystems. Microchips can integrate microfluidic technologies with cells that are cultured within the micro fabricated 3D devices, using various techniques from the microchip industry. 2-dimensional (2D) culture models and animal models have been used for mechanism research and drug development. However, 2D models and animal models cannot mimic the physiology of human tissue, in terms of number of cell types and properties. Thus, conventional models cannot precisely reflect human and have not been able to accurately predict in vivo responses related to drug treatment. In this regard, many industries have been looking for, and developing a new platform, to replace animal models or flask cell-culture models, and recently, organs-on-a-chip (OoCs) emerged as an alternative candidate for cell experiments and drug screening. The main advantage of these chips is that they can be manufactured at low cost. Furthermore, they allow to test a wide range of concentrations in the dosage of medicine. This advantage is expected to drive the demand for microchips, primarily to considerably accelerate scientific research. In recent years, there has been innovative uses of the organ on a chip technology for drug discovery process. North America Captured the Largest Market Share and is Expected to Retain its Dominance North America dominates the overall 3D cell culture market with the United States being the major contributor to the market. The United States is focusing on R&D and has been making significant investments in research on 3D cell culture, for the past few years. This has resulted in technological advancements in the country. Many American applicants feature among the main patent applicants for the 3D cell culture domain. American applicants tend to develop their technologies in the United States, as well as in Asia. There have also been huge investments in the bioengineering sector in the United States over the past few years. Bio engineering involves 3D cell culture research too. Key Topics Covered:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing InSphero

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

InSphero is included in 4 Expert Collections, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

D

Diabetes

1,750 items

B

Biopharma Tech

818 items

InSphero Patents

InSphero has filed 9 patents.

The 3 most popular patent topics include:

  • Aphasias
  • Autosomal recessive disorders
  • Bearings (mechanical)
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/15/2016

4/20/2021

Cell biology, Biotechnology, Molecular biology, Cell culture, Biological databases

Grant

Application Date

4/15/2016

Grant Date

4/20/2021

Title

Related Topics

Cell biology, Biotechnology, Molecular biology, Cell culture, Biological databases

Status

Grant

InSphero Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

InSphero Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.